Development of a Chaff Dispense Program for Target Tracking Radar Deception

This study aims to develop an appropriate chaff dispensing program to deceive the target tracking radar (TTR) effectively. Chaff is a countermeasure commonly used by fighter aircraft to deceive TTR. However, there has been a lack of methodology for calculating chaff dispense programs that take into account the specific characteristics of the fighter, chaff, and TTR. This study proposes a methodology that considers these variables to calculate chaff dispense programs and addresses this gap. The proposed method is demonstrated through TESS engagement, which shows its effectiveness in various engagement situations

Numerical modeling to analysis the abrasion of knee joint by walking pattern

In current studies, growing up of treatment of the knee joint damage such as arthritis, the research to prevent knee joint is under way. As knee joints could be damaged by various types of motion, one of the most influential factor of the abrasion on the knee joint is progressed by walking. It could be classified as 3 types of walking, 1. Walking plain, 2. Climbing stairs or uphill and 3. Going down. In this study, to find the damaged point of knee joint, the following ways would be used. After comparing the knee joint angle with interior and exterior movement of the knee in accordance with the joint dynamics of typical height, the walking pattern for walking up the stairs can be comprehended. It could be shown the variation of the center of rotation of knee joint. From this, the contact point which is pressed on the knee joints in accordance with each walking pattern could be derived. The numerical modeling could be made by quantifying the variety that is caused by the center of mass of knee bone. It would be expected to calculate the contact point on the knee joint through walking patterns. This numerical model is considered of the kinematics system in our knee

Varieties of East Asian Developmentalist Trade Policy: The Trade Liberalization-Industrial Policy Nexus in Thailand and South Korea

This study explores the varieties of East Asian developmentalist trade policy by analyzing Thailands and South Koreas pursuit of free trade agreements (FTAs). Thailand and South Korea offer a nice laboratory to test a neoliberal vs. developmental perspective. After Prime Minister Thaksin took office in 2001, Thailand became a pacesetter in East Asias pursuit of FTAs with its policy nexus of developmentalism and liberalism. However, the lack of institutionalization of trade policy-making process soon led Thaksins CEO-style leadership and pro-business policy bias to cronyism and corruption. In contrast to Thailands abrupt move from developmental liberalism to sectoral cronyism, South Korea has successfully institutionalized its transition from developmental mercantilism to developmental liberalism by strengthening the key trade agency—i.e., the Office of the Minister for Trade, which successfully embedded its industrial policy goals in liberal trade initiatives

Association between the length of stay in rehabilitation and mortality among the adults with Parkinson’s disease: 2009–2019 Korean National Health Insurance Service Databases

BackgroundRehabilitation is recognized as an effective means of alleviating the symptoms of Parkinson’s disease (PD) and improving the physical and cognitive functions of patients with PD. However, research often focuses on short-term outcomes such as functioning and quality of life. This study investigated the association between the length of stay in rehabilitation and mortality among patients with PD.MethodsUsing the Korean National Health Insurance Service database, we identified 636 participants diagnosed with PD who received rehabilitation. The main outcome was all-cause mortality. We used a Cox proportional hazards regression model to examine the relationship between length of stay in rehabilitation and mortality among patients with PD.ResultsThe final sample comprised 374 females (58.81%) and 262 males (41.19%). A survival analysis revealed a significant association between the length of stay in rehabilitation and mortality, with a decrease in mortality of 16.1% in patients with PD who received one year of rehabilitation (hazard ratio = 0.839, 95% confidence interval = 0.788–0.895).ConclusionOur findings underscore the potential benefits of timely implementation of rehabilitative interventions in patients with PD and the need for comprehensive and long-term rehabilitation strategies. It also highlights the necessity of such services for patients with PD and the importance of developing patient-centered rehabilitation guidelines

A Case of Gastritis Associated with Gastric Capillariasis

This report is about the case of gastritis associated with capillariasis. The patient was a 52-yr-old Korean woman who occasionally ate raw fish and chicken. She complained of mild abdominal pain and nausea, but not diarrhea. An endoscopic examination revealed an exudative flat erosive change on the gastric mucosa of the antrum. She was microscopically diagnosed as chronic gastritis with numerous eosinophil infiltrations. The sectioned worms and eggs in mucosa were morphologically regarded as belonging to the genus Capillaria. This is the first case of gastric capillariasis reported in the Republic of Korea

Analysis of benzo[c] phenanthridine alkaloids in Eschscholtzia californica cell culture using HPLC-DAD and HPLC-ESI-MS/MS

Effective HPLC-DAD and HPLC-ESI-MS/MS methods have been developed for the analysis of eight benzo[c] phenanthridine alkaloids (sanguinarine, chelirubine, macarpine, chelerythrine, dihydrosanguinarine, dihydrochelirubine, dihydromacarpine and dihydrochelerythrine), which are important metabolites in Eschscholtzia californica cell culture. By adopting a ternary gradient pump system, the dihydro-form alkaloids hardly separable from each other could be successfully separated, and all the target alkaloids could be simultaneously quantified with the LOD values of 0.01-0.79 mu g/mL and the LOQ values of 0.03-3.59 mu g/mL. This HPLC-DAD method was further confirmed by HPLC-ESI-MS/MS system in multiple reaction monitoring mode. Each separated HPLC peak was identified as the target alkaloid, showing its relevant ionized molecule and selected fragment ion. By applying the established method, alkaloid production during the E. californica cell culture could be successfully monitored and some valuable information on its metabolism could be deduced.11Ysciescopu

Comparative analysis of FBS containing media and serum free chemically defined media, CellCor for adipose derived stem cells production

Background: As a result of the aging society, the average OECD life expectancy has grown to about 80 years, yet the average health life still remains at only 65 years, leaving more than 15 years of life in an uncertain health state. Regenerative medicine is a new concept of medicine that combines cells and biomaterials to restore the functions of aged or damaged tissues or organs. It is also a good treatment for chronic diseases and incurable diseases, receiving attention as a new paradigm for treating diseases. Problems: As the market for regenerative medicine grows, mass production of consistent quality cells is required. Media is the most important thing in mass production of consistent quality cells. However, the fetal bovine serum (FBS) containing media that is currently wide used has many problems, such as unidentified viral infection, immunogenicity, lot variations, unstable supply, and ethical issues. To solve these problems and make rapid progress in regenerative medicine, a high-performance serum free chemically defined media (CDM) is needed. Solution: CellCor is a serum free CDM that provides excellent performance, safety, economy and consistency in stem cell production. CellCor allows higher-speed cell production rate than current FBS containing culture media (Figure 1). Compared to the FBS containing media, CellCor is able to maintain stem cell markers, higher population homogeneity, genetic stability, and excellent differentiation potency even at later passage. Please click Additional Files below to see the full abstract

SKYSCRAPER-02: Tiragolumab in Combination With Atezolizumab Plus Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer

Tiragolumab; Chemotherapy; Small-cell lung cancerTiragolumab; Quimioteràpia; Càncer de pulmó de cèl·lules petitesTiragolumab; Quimioterapia; Cáncer de pulmón de células pequeñasPurpose The phase III SKYSCRAPER-02 study determined whether the benefits of atezolizumab plus carboplatin and etoposide (CE) could be enhanced by the addition of tiragolumab in untreated extensive-stage small-cell lung cancer (ES-SCLC). We report final progression-free survival (PFS) and overall survival (OS) analyses. Methods Patients received tiragolumab 600 mg/placebo, plus atezolizumab 1,200 mg and CE (four cycles), then maintenance tiragolumab/placebo plus atezolizumab. Primary end points were investigator-assessed PFS and OS in patients without history/presence of brain metastases (primary analysis set [PAS]). Additional end points included PFS and OS in all patients regardless of brain metastases status (full analysis set [FAS]), response, and safety. Results Four hundred ninety patients were randomly assigned (FAS): 243 to tiragolumab arm and 247 to control arm. At the cutoff date (February 6, 2022; median duration of follow-up, 14.3 months [PAS] and 13.9 months [FAS]), final analysis of PFS in the PAS (n = 397) did not reach statistical significance (stratified hazard ratio [HR], 1.11; P = .3504; median, 5.4 months tiragolumab v 5.6 months control). At the cutoff date (September 6, 2022; median duration of follow-up, 21.2 months [FAS]), median OS in the PAS at final OS analysis was 13.1 months in both arms (stratified HR, 1.14; P = .2859). Median PFS and OS in the FAS were consistent with the PAS. The proportion of patients with immune-mediated adverse events (AEs) in the tiragolumab and control arms was 54.4% and 49.2%, respectively (grade 3/4: 7.9% and 7.7%). AEs leading to treatment withdrawal occurred in 8.4% and 9.3% of tiragolumab- and control-treated patients, respectively. Conclusion Tiragolumab did not provide additional benefit over atezolizumab and CE in untreated ES-SCLC. The combination was well tolerated with no new safety signals.Supported by Genentech Inc and F. Hoffmann-La Roche Ltd. C.M.D.'s work on small cell lung cancer is supported by NIH R35CA263816, U24CA13274, and P30CA008748